Lung Maturation in Preterm Infants

Embed Size (px)

Citation preview

  • 8/11/2019 Lung Maturation in Preterm Infants

    1/23

    LUNGMATURATIONINPRETERMINFANTS

    Pembimbing :

    dr. Gioseffi, Sp.OG

    Disusun oleh :

    Karlina Liwang / 406121003Krisma Kristiana / 406121004

  • 8/11/2019 Lung Maturation in Preterm Infants

    2/23

    PRELIMINARY

    To this day, neonatal mortality and morbidity in

    preterm infants is still high.

    This is related to the maturity of the babysorgans

    such as the lungs, brain, and gastrointestinal.

    Good obstetric approach to preterm labor will give

    hope to the survival and quality of life of premature

    infants.

    Respiratory distress syndrom is the leading cause

    of death for babies born prematurely.

  • 8/11/2019 Lung Maturation in Preterm Infants

    3/23

    LUNGMATURATIONINPRETERMINFANTS

    Premature babies are babies born at gestational

    age less than 37 weeks.

    Antenatal corticosteroid therapy in women who are

    at high risk for preterm delivery has been

    recommended.

    Corticosteroid therapy in pregnant women who will

    deliver prematurely used to enhance fetal lung

    maturation.

  • 8/11/2019 Lung Maturation in Preterm Infants

    4/23

    DEFINITIONSANDCRITERIAOFRESPIRATORY

    DISTRESSSYNDROM

    Dypsnea

    Tachypnea

    Persistent cyanosis

    On chest radiograph: patchy alveolar infiltrates,atelectasis, vaskular congestion, hemorrhage,

    pulmonary edema

  • 8/11/2019 Lung Maturation in Preterm Infants

    5/23

    IMPORTANTFACTORINTHESURFACTANT

    DEFICIENCY

    Premature

    Perinatal asfiksia

    Maternal diabetic

    Seksio sesaria

  • 8/11/2019 Lung Maturation in Preterm Infants

    6/23

    Respiratory Distress Syndrom (RDS) or Hyaline

    Membran Disease (HMD) obtained in 10% ofpremature infants, due to a deficiency of surfactant

    in infants born with a gestational age of less.

    Surfactant is usually found in the mature

    pulmonary. Surfactant function : keep the alveoli pockets keep

    growing and air filled. So in preterm infants, where

    surfactant undeveloped cause growing power of

    lung reduced and the infants experiencing

    shortness of breath. The symptom appeared soon

    after the baby is born and getting worse.

  • 8/11/2019 Lung Maturation in Preterm Infants

    7/23

    Clinical symptoms were seen:

    Takipnea in newborns (>60x/minutes)

    Nostril breathing

    Grunting

    Intercostal retraction

    Sianosis

    The symptom settled within 48-96 hours after birth.

  • 8/11/2019 Lung Maturation in Preterm Infants

    8/23

    On chest radiograph, criteria Bomsel there are 4

    stage, namely :

    Stage 1 : there are very few spots retikulogranular and

    few airbronchogram.

    Stage 2 : spots retikulogranular homogeneous on bothlungs and air bronchogram seen more clearly and

    extends to the peripheral cover the heart shadow with

    decreased lung aeration.

    Stage 3 : collection of collapsed alveoli so both lungs

    field appear more opaque and the heart shadow almost

    invisible, airbronchogram wider.

    Stage 4 : all of thorax very opaque (white lung) so the

    heart cantbe seen.

  • 8/11/2019 Lung Maturation in Preterm Infants

    9/23

    PATHOPHYSIOLOGYRESPIRATORYDISTRESS

    SYNDROMONPREMATUREINFANTS

    Thoraks wall still weak

    Production of surfactantisnt perfect

    Collaps alveolus

    The lungs become stiff

  • 8/11/2019 Lung Maturation in Preterm Infants

    10/23

    CORTICOSTEROIDSINLUNGMATURATION

    Physiological effect glucocorticoid on lung

    maturation is increase lung surfactant.

    And also increased lung compliance and maximal

    volume of lungs.

    Glucocorticoid its also increase activity of

    antioxidant enzym and induce proteins involved in

    the clearance of air lung. This is used to help

    breathing.

  • 8/11/2019 Lung Maturation in Preterm Infants

    11/23

    THEUSEDOFCORTICOSTEROIDSON

    ANTENATAL

    Corticosteroid antenatal on pregnant women at risk

    of preterm birth is one therphy the most efective

    and important.

    Corticosteroids can repaired function of infants lung

    and protected infants of premature death.

  • 8/11/2019 Lung Maturation in Preterm Infants

    12/23

    INDICATIONOFANTENATALCORTICOSTEROIDAT24

    34 WEEKSOFGESTATION

    Preterm labor

    Haemorragic antepartum

    Premature ruptur of the membran (PROM)

  • 8/11/2019 Lung Maturation in Preterm Infants

    13/23

    Doses used for :

    Deksametason 6mg intramuskular : 4 times at intervals

    of 12 hours.

    Betametason 12 mg intramuskular : 2 times at intervals

    of 24 hours.

    Higher dose or more frequency, its not enhance

    benefits of corticosteroid theraphy and actually

    increase the loss of effect.

  • 8/11/2019 Lung Maturation in Preterm Infants

    14/23

    TIMINGOFCORTICOSTEROID

    Based on between the time interval and birth, the

    baby will born 48 hours up to 7 days after theraphy

    of glucocorticoid, provide the greatest benefit.

    Levels of surfactant can decreases again in time 8

    up to 10 days.

    Repeated theraphy if baby birth has not occurred

    on 7 days since the first theraphy and the risk of

    premature birth still have.

  • 8/11/2019 Lung Maturation in Preterm Infants

    15/23

  • 8/11/2019 Lung Maturation in Preterm Infants

    16/23

    Antenatal corticosteroid its not recommended

    before gestational age 24 weeks and after 34

    weeks.

    All fetuses at risk preterm delivery can be

    considered antenatal corticosteroid theraphy on

    gestational age 2434 weeks.

  • 8/11/2019 Lung Maturation in Preterm Infants

    17/23

    CORTICOSTEROIDINMULTIPLEPERGNANCY

    Multiple pregnancy can increased the risk for

    premature labor.

    Twin pregnancy have the risk >40% for premature

    labor.

    Antenatal corticosteroid in multiple pregnancy its

    recommended, but significant reduction RDS not

    been demonstrated.

  • 8/11/2019 Lung Maturation in Preterm Infants

    18/23

    ADVANTAGEANTENATALCORTICOSTEROIDS

    Theraphy antenatal corticosteroid in preterm infants

    shown to reduce neonatal mortality and incident

    RDS.

  • 8/11/2019 Lung Maturation in Preterm Infants

    19/23

    DISADVANTAGEOFGIVINGANTENATAL

    CORTICOSTEROID

    Risks to the fetus and neonatus after giving

    antenatal glucocorticoid is rare to happens and

    reversible.

    The most common complications of corticosteroids

    antenatal is infection and supretion adrenal.

  • 8/11/2019 Lung Maturation in Preterm Infants

    20/23

    REPEATANTENATALCORTICOSTEROID

    Not known advantages and effects of theraphy

    repeat antenatal corticosteroid. But, many docters

    used theraphy repeat antenatal corticosteroid every

    weeks until 34 weeks gestational weeks.

  • 8/11/2019 Lung Maturation in Preterm Infants

    21/23

    CONCLUSION

    Premature babies are born on gestational age < 37

    weeks have a high risk for prematurity diseases.

    Antenatal corticosteroid used to helped matury of

    infants lungs.

    Antenatal cortocosteroids on pregnant women is

    recommended for who have the risk have

    premature delivery up to 7 days ahead.

    Drugs used are betametason and deksametason,

    often called glococorticoid, given antenatal for push

    ahead maturity of infants lung.

  • 8/11/2019 Lung Maturation in Preterm Infants

    22/23

    Antenatal corticosteroid can increased outcome on

    babies who have born on gestational age 24 -34

    weeks.

    And also more usefull if childbirth happens at least

    on 24 hours after first dosing and before 7 days

    after the last dosing drug.

  • 8/11/2019 Lung Maturation in Preterm Infants

    23/23